PROCESS FOR PREPARING CLOPIDOGREL

Information

  • Patent Application
  • 20070225320
  • Publication Number
    20070225320
  • Date Filed
    March 26, 2007
    17 years ago
  • Date Published
    September 27, 2007
    17 years ago
Abstract
A process for preparing clopidogrel or a salt thereof.
Description

BRIEF DESCRIPTION OF THE DRAWING


FIG. 1 is a schematic representation of processes of the present invention.


Claims
  • 1. A process for preparing clopidogrel or a salt thereof, comprising reacting racemic methyl alpha-amino-(2-chlorophenyl)acetate with L-(+)-tartaric acid, separating a formed tartaric acid salt of S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate from a reaction mixture, and heating a reaction mixture to form racemic methyl alpha-amino-(2-chlorophenyl)acetate.
  • 2. The process of claim 1, wherein a starting material methyl α-amino-(2-chlorophenyl)acetic acid is prepared by reacting DL-2-chlorophenylglycine with methanol in the presence of sulfuric acid.
  • 3. The process of claim 1, wherein reacting with L-(+)-tartaric acid occurs in the presence of a solvent consisting essentially of methanol.
  • 4. The process of claim 1, wherein heating a reaction mixture is carried out at temperatures about 30° C. to about 100° C.
  • 5. The process of claim 1, wherein formed racemic methyl alpha-amino-(2-chlorophenyl)acetate is reacted with additional L-(+)-tartaric acid to form a tartaric acid salt of S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate.
  • 6. The process of claim 1, further comprising reacting a tartaric acid salt of S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate with a base to form S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate, which is reacted with 2-thienyl-p-toluenesulfonate to form a reaction product, and further reacting a reaction product with formaldehyde to form clopidogrel.
  • 7. The process of claim 6, wherein 2-thienyl-p-toluenesulfonate is prepared by reacting thiophene-2-ethanol with a p-toluene sulfonyl halide, in a solvent comprising toluene.
  • 8. The process of claim 6, wherein a base comprises sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, or potassium bicarbonate.
  • 9. The process of claim 6, wherein formaldehyde is used in the form of an aqueous solution having a concentration about 40 percent by weight, in a volume about 3 L to about 15 L per kg of S-(+)-methyl α-(2-thienylethylamino)-(2-chlorophenyl)acetate.
  • 10. The process of claim 6, further comprising reacting clopidogrel with sulfuric acid to form clopidogrel hydrogen sulfate.
  • 11. The process of claim 10, wherein clopidogrel hydrogen sulfate has crystalline Form I.
  • 12. The process of claim 10, wherein clopidogrel hydrogen sulfate has crystalline Form II.
  • 13. A continuous process for preparing clopidogrel or a salt thereof, comprising reacting racemic methyl alpha-amino-(2-chlorophenyl)acetate with L-(+)-tartaric acid, separating a formed tartaric acid salt of S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate from a reaction mixture, heating a reaction mixture to form racemic methyl alpha-amino-(2-chlorophenyl)acetate, and reacting formed racemic methyl alpha-amino-(2-chlorophenyl)acetate with additional L-(+)-tartaric acid to form a tartaric acid salt of S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate.
  • 14. The process of claim 13, wherein reacting with L-(+)-tartaric acid occurs in the presence of a solvent consisting essentially of methanol.
  • 15. The process of claim 13, wherein heating a reaction mixture is carried out at temperatures about 30° C. to about 100° C.
  • 16. The process of claim 13, further comprising reacting a tartaric acid salt of S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate with a base to form S-(+)-methyl alpha-amino-(2-chlorophenyl)acetate, which is reacted with 2-thienyl-p-toluenesulfonate to form a reaction product, and further reacting a reaction product with formaldehyde to form clopidogrel.
  • 17. The process of claim 16, wherein 2-thienyl-p-toluenesulfonate is prepared by reacting thiophene-2-ethanol with a p-toluene sulfonyl halide, in a solvent comprising toluene or dichloromethane.
  • 18. A process for preparing 2-thienyl-p-toluenesulfonate, comprising reacting thiophene-2-ethanol with a p-toluene sulfonyl halide, in a solvent comprising toluene or dichloromethane.
  • 19. The process of claim 18, wherein reacting is conducted in the presence of a base.
  • 20. The process of claim 18, wherein reacting is conducted in the presence of triethylamine.
Priority Claims (1)
Number Date Country Kind
545/CHE/2006 Mar 2006 IN national
Provisional Applications (1)
Number Date Country
60807783 Jul 2006 US